Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 3/2011

01.03.2011 | Glaucoma

Levels of plasma homocysteine in pseudoexfoliation glaucoma

verfasst von: Laura Tranchina, Marco Centofanti, Francesco Oddone, Lucia Tanga, Gloria Roberti, Laura Liberatoscioli, Claudio Cortese, Gianluca Manni

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

To examine levels of serum homocysteine (Hcy), vitamin B12 and folic acid in patients with pseudoexfoliation glaucoma (PEXG), primary open-angle glaucoma (POAG), and healthy control subjects.

Methods

This study included 36 patients with PEXG, 40 with POAG, and 40 age-matched healthy subjects. Fasting plasma Hcy concentrations and levels of serum vitamin B12 and folic acid were measured using competitive chemiluminescent enzyme immunoassay; values exceeding 14 μm/l were considered elevated.

Results

Mean plasma Hcy was significantly higher in PEXG (16.55 ± 7.23 μm/l) compared with POAG (13.91 ± 3.61 μm/l) and controls (13.12 ± 5.13 μm/l) (p = 0.03 and p = 0.0007 respectively).
There were no statistical differences in serum vitamin B12 and folic acid levels among PEXG, POAG and control subjects (p > 0.05). A moderate, although statistically significant, relationship between Hcy and folic acid levels was found in the PEXG group (R2 = 0.23, p = 0.003). Hcy levels were found not to be related with folic acid or vitamin B12 in either POAG or control subjects.

Conclusions

In this study, plasma Hcy is significantly higher in PEXG group than the POAG and control groups. Hyper-Hcy might play a role in the pathogenesis of PEXG. Hyper-Hcy may be an independent factor stressing vasculopathy in addition to pseudoexfoliation, so might be a modifiable risk factor for PEXG.
Literatur
1.
Zurück zum Zitat Ritch R, Schlotzer-Schrehardt U (2001) Exfoliation syndrome: toward a new understanding: proceedings of the First International Think Tank. Acta Ophthalmol Scand 79:213–217PubMedCrossRef Ritch R, Schlotzer-Schrehardt U (2001) Exfoliation syndrome: toward a new understanding: proceedings of the First International Think Tank. Acta Ophthalmol Scand 79:213–217PubMedCrossRef
2.
Zurück zum Zitat Ritch R (1994) Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma. J Glaucoma 3:176–178PubMed Ritch R (1994) Exfoliation syndrome: the most common identifiable cause of open-angle glaucoma. J Glaucoma 3:176–178PubMed
3.
4.
Zurück zum Zitat Schlotzer-Schrehardt U, Naumann GO (2006) Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141:921–937PubMedCrossRef Schlotzer-Schrehardt U, Naumann GO (2006) Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141:921–937PubMedCrossRef
5.
Zurück zum Zitat Hayreh SS (2001) Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 20:595–624PubMedCrossRef Hayreh SS (2001) Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 20:595–624PubMedCrossRef
6.
Zurück zum Zitat Weinreb RN, Cioffi GA, Harris A (1997) Optic nerve blood flow. In: Van Buskirk EM, Shields B (eds) 100 Years of Progress in Glaucoma. Lippincott-Raven, Philadelphia, pp 59–78 Weinreb RN, Cioffi GA, Harris A (1997) Optic nerve blood flow. In: Van Buskirk EM, Shields B (eds) 100 Years of Progress in Glaucoma. Lippincott-Raven, Philadelphia, pp 59–78
7.
Zurück zum Zitat Lee DJ, Gomez-Marin O, Lam BL (2003) Glaucoma and survival: the national health interview survey 1986-1994. Ophthalmology 110:1476–1483PubMedCrossRef Lee DJ, Gomez-Marin O, Lam BL (2003) Glaucoma and survival: the national health interview survey 1986-1994. Ophthalmology 110:1476–1483PubMedCrossRef
8.
Zurück zum Zitat Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefánsson E (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21:359–393PubMedCrossRef Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, Renard JP, Stefánsson E (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21:359–393PubMedCrossRef
9.
Zurück zum Zitat Bleich S, Naumann GOH, Kornhuber J (2002) Homocysteine and risk of open angle glaucoma. J Neural Transm 109:1499–1504PubMedCrossRef Bleich S, Naumann GOH, Kornhuber J (2002) Homocysteine and risk of open angle glaucoma. J Neural Transm 109:1499–1504PubMedCrossRef
10.
Zurück zum Zitat Finklestein JD (1998) The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157:40–44CrossRef Finklestein JD (1998) The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157:40–44CrossRef
11.
Zurück zum Zitat Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation with increased vascular risk. Am J Ophthalmol 124:685–687PubMed Mitchell P, Wang JJ, Smith W (1997) Association of pseudoexfoliation with increased vascular risk. Am J Ophthalmol 124:685–687PubMed
12.
Zurück zum Zitat Stampfer MJ, Willet WC (1992) A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 268:877–881PubMedCrossRef Stampfer MJ, Willet WC (1992) A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 268:877–881PubMedCrossRef
13.
Zurück zum Zitat Perry IJ, Morris RW (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395–1398PubMedCrossRef Perry IJ, Morris RW (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395–1398PubMedCrossRef
14.
Zurück zum Zitat Vine AK (2000) Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 129:640–644PubMedCrossRef Vine AK (2000) Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 129:640–644PubMedCrossRef
15.
Zurück zum Zitat Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A (2000) Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 107:1588–1592PubMedCrossRef Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A (2000) Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 107:1588–1592PubMedCrossRef
16.
Zurück zum Zitat Bleich S, Roedl J, Von Ahsen N, Schlötzer-Schrehardt U, Reulbach U, Beck G, Kruse FE, Naumann GO, Kornhuber J, Jünemann AG (2004) Elevated homocysteine in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol 138:162–164PubMedCrossRef Bleich S, Roedl J, Von Ahsen N, Schlötzer-Schrehardt U, Reulbach U, Beck G, Kruse FE, Naumann GO, Kornhuber J, Jünemann AG (2004) Elevated homocysteine in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol 138:162–164PubMedCrossRef
17.
Zurück zum Zitat Leibovitch I, Kurtz S, Shemesh G, Goldstein M, Sela BA, Lazar M, Loewenstein A (2003) Hyperhomocysteinemia in pseudoexfoliation glaucoma. J Glaucoma 12:36–39PubMedCrossRef Leibovitch I, Kurtz S, Shemesh G, Goldstein M, Sela BA, Lazar M, Loewenstein A (2003) Hyperhomocysteinemia in pseudoexfoliation glaucoma. J Glaucoma 12:36–39PubMedCrossRef
18.
Zurück zum Zitat Vessani RM, Ritch R, Liebmann JM, Jofe M (2003) Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 136:41–46PubMedCrossRef Vessani RM, Ritch R, Liebmann JM, Jofe M (2003) Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 136:41–46PubMedCrossRef
19.
Zurück zum Zitat Clement CI, Goldberg I, Healey PR, Graham SL (2009) Plasma homocysteine, MTHFR gene mutation, and open-angle glaucoma. J Glaucoma 18:73–78PubMedCrossRef Clement CI, Goldberg I, Healey PR, Graham SL (2009) Plasma homocysteine, MTHFR gene mutation, and open-angle glaucoma. J Glaucoma 18:73–78PubMedCrossRef
20.
Zurück zum Zitat Michael S, Qamar R, Akhtar F, Khan WA, Ahmed A (2009) MTHFR gene C677T and A1298C polymorphisms and homocysteine levels in primary open angle and primary closed angle glaucoma. Molecular Vision 15:1090 Michael S, Qamar R, Akhtar F, Khan WA, Ahmed A (2009) MTHFR gene C677T and A1298C polymorphisms and homocysteine levels in primary open angle and primary closed angle glaucoma. Molecular Vision 15:1090
21.
Zurück zum Zitat Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50:3–32PubMedCrossRef Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM (2004) Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50:3–32PubMedCrossRef
22.
Zurück zum Zitat Demuth K, Ducros V, Michelsohn S, Paul JL (2004) Evaluation of Advia Centaur automated chemiluminescence immunoassay for determining total homocysteine in plasma Clin Chim Acta 349(1–2):113–120 Demuth K, Ducros V, Michelsohn S, Paul JL (2004) Evaluation of Advia Centaur automated chemiluminescence immunoassay for determining total homocysteine in plasma Clin Chim Acta 349(1–2):113–120
23.
Zurück zum Zitat Cumurcu T, Sahin S, Aydin E (2006) Serum homocysteine, vitamin B12 and folic acid levels in different types of glaucoma. BMC Ophthalmol 6:6PubMedCrossRef Cumurcu T, Sahin S, Aydin E (2006) Serum homocysteine, vitamin B12 and folic acid levels in different types of glaucoma. BMC Ophthalmol 6:6PubMedCrossRef
24.
Zurück zum Zitat Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genetics 10:111–113CrossRef Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genetics 10:111–113CrossRef
25.
Zurück zum Zitat Puustjärvi T, Blomster H, Kontkanen M, Punnonen K, Teräsvirta M (2004) Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 242:749–754PubMedCrossRef Puustjärvi T, Blomster H, Kontkanen M, Punnonen K, Teräsvirta M (2004) Plasma and aqueous humour levels of homocysteine in exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 242:749–754PubMedCrossRef
26.
Zurück zum Zitat Altintaş O, Maral H, Yüksel N, Karabaş VL, Dillioğlugil MO, Cağlar Y (2005) Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 243(7):677–683PubMedCrossRef Altintaş O, Maral H, Yüksel N, Karabaş VL, Dillioğlugil MO, Cağlar Y (2005) Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 243(7):677–683PubMedCrossRef
27.
Zurück zum Zitat Turgut B, Kaya M, Arslan S, Demir T, Güler M, Kaya MK (2010) Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma. Clin Interv Aging 26(5):133–139CrossRef Turgut B, Kaya M, Arslan S, Demir T, Güler M, Kaya MK (2010) Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma. Clin Interv Aging 26(5):133–139CrossRef
28.
Zurück zum Zitat Turaçli ME, Tekeli O, Ozdemir F, Akar N (2005) Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation. Clin Experiment Ophthalmol 33(5):505–8PubMedCrossRef Turaçli ME, Tekeli O, Ozdemir F, Akar N (2005) Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation. Clin Experiment Ophthalmol 33(5):505–8PubMedCrossRef
29.
Zurück zum Zitat Moore P, El-sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB (2001) Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res 73:45–57PubMedCrossRef Moore P, El-sherbeny A, Roon P, Schoenlein PV, Ganapathy V, Smith SB (2001) Apoptotic cell death in the mouse retinal ganglion cell layer is induced in vivo by the excitatory amino acid homocysteine. Exp Eye Res 73:45–57PubMedCrossRef
30.
Zurück zum Zitat Tyagi SC, Lominadze D, Roberts AM (2005) Homocysteine in microvascular endothelial cell barrier permeability. Cell Biochem Biophys 43:37–44PubMedCrossRef Tyagi SC, Lominadze D, Roberts AM (2005) Homocysteine in microvascular endothelial cell barrier permeability. Cell Biochem Biophys 43:37–44PubMedCrossRef
31.
Zurück zum Zitat Naumann GO, Schlotzer-Schrehardt U, Kuchle M (1998) Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology 105:951–968PubMedCrossRef Naumann GO, Schlotzer-Schrehardt U, Kuchle M (1998) Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology 105:951–968PubMedCrossRef
32.
Zurück zum Zitat Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, Giusti B, Pratesi C, Pulli R, Gensini GF, Abbate R, Pepe G (2000) High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 32:531–536PubMedCrossRef Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, Giusti B, Pratesi C, Pulli R, Gensini GF, Abbate R, Pepe G (2000) High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 32:531–536PubMedCrossRef
33.
Zurück zum Zitat Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 357:407–413CrossRef Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 357:407–413CrossRef
Metadaten
Titel
Levels of plasma homocysteine in pseudoexfoliation glaucoma
verfasst von
Laura Tranchina
Marco Centofanti
Francesco Oddone
Lucia Tanga
Gloria Roberti
Laura Liberatoscioli
Claudio Cortese
Gianluca Manni
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 3/2011
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-010-1487-6

Weitere Artikel der Ausgabe 3/2011

Graefe's Archive for Clinical and Experimental Ophthalmology 3/2011 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.